Investment Manager, Melbourne
Michael joined Brandon Capital Partners as an Investment Manager in February 2016.
Previously, Michael was the Senior Business Development Manager at Monash University where he managed the Life Science portfolio for the Faculty of Medicine. In this role he identified numerous new research opportunities and led multiple negotiations on high value licensing and partnering transactions. His prior experience in commercialisation and investment also includes 5 years as an Investment Manager (Life Sciences) at the TTCF, a small commercialisation fund focussed on investing capital in opportunities derived from academic research, where he led diligence on Life Science investee companies such as Nexvet (NASDAQ – NVET) and Heart Metabolics – both now a part of the Brandon Capital Partners portfolio. Michael’s research experience includes a Roche Research Foundation post-doctoral fellowship at the ISREC (EPFL) in Lausanne, Switzerland. He holds a PhD from the University of Adelaide and an MBA specialising in technology management from La Trobe University.